A Comprehensive Review of Local Treatment Options for Hidradenitis Suppurativa: Current Strategies and Challenges - Top-Institutions - MDSpire

A Comprehensive Review of Local Treatment Options for Hidradenitis Suppurativa: Current Strategies and Challenges

  • By

  • Elisa Molinelli

  • Davide Febi

  • Edoardo De Simoni

  • Maria Luisa Dragonetti

  • Irene Richiardi

  • Matteo Candelora

  • Daisy Gambini

  • Sara Belleggia

  • Guendalina Lucarini

  • Oriana Simonetti

  • March 18, 2026

  • 0 min

Share

Top Institutions in Dermatology

Brief introduction explaining scope and methodology.

  • #1

    University of Pennsylvania Perelman School of Medicine
    University of Pennsylvania Perelman School of Medicine

    Philadelphia, PA

    Key Differentiators

    • Dermatology
    • Inflammatory Skin Diseases
    • Clinical Research

  • #2

    University of California, San Francisco (UCSF) School of Medicine
    University of California, San Francisco (UCSF) School of Medicine

    San Francisco, CA

    Key Differentiators

    • Dermatology
    • Inflammatory Skin Diseases
    • Clinical Trials

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Dermatology
    • Clinical Research
    • Inflammatory Skin Diseases

  • #4

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Dermatology
    • Inflammatory Skin Diseases
    • Clinical Research

  • #5

    King’s College London, Dermatology Department
    King’s College London, Dermatology Department

    London, N/A

    Key Differentiators

    • Dermatology
    • Inflammatory Skin Diseases
    • Clinical Research

Original Source(s)

A Comprehensive Review of Local Treatment Options for Hidradenitis Suppurativa: Current Strategies and Challenges

  • by Elisa Molinelli, Davide Febi, Edoardo De Simoni, Maria Luisa Dragonetti, Irene Richiardi, Matteo Candelora, Daisy Gambini, Sara Belleggia, Guendalina Lucarini, Oriana Simonetti

  • March 18, 2026

Related Content

HS Linked to Higher Cancer Risk

Investigators report site-specific cancer associations and limited adjusted estimates in meta-analysis.

Financial Impact of Hidradenitis Suppurativa in Spain

This Week’s Biopharma News: Amgen Deepens US Manufacturing Push

The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production

  • May 12, 2026

  • 7 min